The Ledger
Digital health investors funded fewer companies than dealmakers bought this spring, with 71 corporate acquisitions closing in the second quarter of 2026 alone, the busiest three months for digital health M&A since the height of the 2021 bull market. Rock Health’s mid-year report found United States digital health startups raised 7.4 billion dollars across 244 deals in the first half of 2026, up from 6.4 billion dollars in the same period a year earlier on roughly the same number of rounds, but 20 mega deals of 100 million dollars or more, just 8 percent of all financings, absorbed 45 percent of the capital, pushing the median deal size to 14 million dollars from 12 million in 2025. Beneath that concentration, the report counted 115 corporate acquisitions of digital health companies in the first half, with mental health the top funded clinical indication for a seventh straight year and weight management close behind as GLP-1 and consumer peptide products draw capital. Confidence: High. Source: H1 2026 funding and market overview, Rock Health.
XRHealth bought Swing Therapeutics, maker of the first FDA-authorized digital treatment for fibromyalgia, its sixth acquisition in two years and its first move beyond extended-reality headsets into smartphone-based treatment. The July 15, 2026 deal, terms undisclosed, brings XRHealth Swing’s Stanza program, a prescription digital therapeutic that earned FDA De Novo authorization for fibromyalgia symptoms and showed significant improvements in pain intensity, fatigue, sleep and depression in a Phase 3 randomized controlled trial published in The Lancet. It also adds Swing Care, a virtual specialty clinic pairing Stanza with medication management and coaching, where 88.0 percent of patients reported improved wellbeing at one year and 50.2 percent rated themselves “much improved” or better. XRHealth is licensed across 22 states and already works through Medicare Part B, the Department of Veterans Affairs and commercial insurance; fibromyalgia affects an estimated 10 million Americans. Confidence: High on the deal’s terms and description; Low on its financial size, since the price was not disclosed. Source: XRHealth’s acquisition announcement, PRWeb.
Cross Country Healthcare’s stockholders voted this week to take one of the industry’s largest publicly traded travel-nurse and allied-clinician staffing firms private, clearing the last major hurdle in a 437 million dollar buyout. At a July 16, 2026 special meeting, holders of 23,356,105 shares voted to adopt the merger agreement against just 12,309 opposed, approving Knox Lane’s all-cash offer of 13.25 dollars a share, an approximately 31 percent premium to Cross Country’s May 6, 2026 closing price and about 45 percent above its 90-day volume-weighted average price at the time the deal was struck. The San Francisco-based private equity firm’s acquisition vehicle, KL Criss Cross Intermediate, is expected to close the deal in the third quarter of 2026, at which point Cross Country will delist from Nasdaq and stop filing as a public company. Confidence: High. Source: Cross Country Healthcare’s Form 8-K on stockholder approval, U.S. Securities and Exchange Commission.
FRONTIER SCAN: medical office buildings, the unglamorous outpatient real estate quietly absorbing care that used to happen inside hospitals, just posted their strongest quarterly investment volume in years, and a Dallas healthcare real estate firm’s latest purchase shows why capital keeps flowing there. CBRE’s first-quarter 2026 report on United States medical outpatient buildings found investment volume rose 78 percent year over year to 2.9 billion dollars, 15 percent above the five-year first-quarter average and lifting the trailing four-quarter total to 13.9 billion dollars; the average cap rate fell 13 basis points to 6.9 percent, the first time it has dropped below 7.0 percent since the third quarter of 2024, while average asking rent hit a record 25.40 dollars per square foot. Big Sky Medical, a Dallas-based healthcare real estate investment manager, closed on RidgeWood Medical Center I and II, a two-building outpatient campus in San Antonio, on July 9, 2026, terms undisclosed, its third and fourth acquisitions through Big Sky Fund III since the fund launched in December 2025. Big Sky has now announced two healthcare real estate acquisitions in the span of a week, following its purchase of HealthCap Partners on July 15; its recurring, near-weekly dealmaking makes its own newsroom worth tracking directly alongside CBRE’s quarterly figures (added 2026-07-20, frontier scan). Confidence: High on both the CBRE figures and the RidgeWood transaction; Low on RidgeWood’s price, since it was not disclosed. Sources: Q1 2026 U.S. Medical Outpatient Buildings Figures, CBRE, Big Sky Medical’s acquisition announcement, GlobeNewswire.
THE DEAL SHEET
| Target | Acquirer/Investor | Vertical | Value | Source |
|---|---|---|---|---|
| Cross Country Healthcare, Inc. | Knox Lane (KL Criss Cross Intermediate, LLC) | Healthcare staffing, travel nursing and allied clinicians | $13.25/share cash, approximately $437 million | Cross Country Healthcare’s Form 8-K on stockholder approval, U.S. Securities and Exchange Commission |
| RidgeWood Medical Center I & II, San Antonio | Big Sky Medical (Big Sky Fund III) | Healthcare real estate, medical outpatient buildings | Undisclosed | Big Sky Medical’s acquisition announcement, GlobeNewswire |
| Swing Therapeutics, Inc. | XRHealth | Digital health, chronic pain and fibromyalgia digital therapeutics | Undisclosed | XRHealth’s acquisition announcement, PRWeb |
| Lyons Magnus | Truelink Capital (from Paine Schwartz Partners) | Specialty ingredients and healthcare nutrition manufacturing | Undisclosed | Truelink Capital’s acquisition announcement, PR Newswire |
HCA Healthcare’s second-quarter earnings call is set for July 24. Molina reports July 22, Community Health Systems around July 22 to 23, Universal Health Services July 27, Centene around July 28, Humana and Privia Health both around July 29 to August 6, and Cigna July 30.